左心房复合对慢性心力衰竭与心房功能性心肌回的影响
Kosuke Nakamae1, Takashi Oshitomi1, Hideyuki Uesugi1
1Division of Cardiovascular Surgery, Saiseikai Kumamoto Hospital, 5-3-1, Cikami, Minami-Ku, Kumamoto, 861-4193 Japan.
Indian journal of thoracic and cardiovascular surgery
|December 21, 2023
概括
左心房复合 (LAP) 有效地减少了巨大的左心房大小,改善了心力衰竭症状和心心膜吐. 这种手术技术为管理与心房扩大相关的心力衰竭提供了有前途的方法.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
背景情况:
- 一个巨大的左心室可以压缩左心室,恶化腹功能障碍和心力衰竭.
- 耳前功能性 mitra 反是与左心房扩大相关的常见并发症.
研究的目的:
- 为了评估左心脏复合 (LAP) 对心脏功能性心肌吐的影响.
- 为了评估LAP在减轻心力衰竭症状的有效性,在患有巨型左心房的患者.
主要方法:
- 在2017年1月至2021年12月期间,对18名接受LAP治疗的患者进行了回顾性评估,这些患者因心房功能性腹吐而受到LAP治疗.
- 在LAP+和LAP-组之间比较早期结果,心声图数据和心力衰竭指标.
主要成果:
- 在LAP+组中,术后左心房体积显著减少.
- 在这两组中,心肌反受控到轻度以下的水平.
- 在随访时,LAP+组表现出左心室末端透缩体积减少和心力衰竭指标改善.
结论:
- 左心房复合是有效的控制心房功能性 mitra 吐和改善心力衰竭.
- 长期监测至关重要,因为可能导致左心房再扩张.
相关概念视频
Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


